In the afternoon on May 5, Daojun Song, secretary of the Work Committee of High-tech Development Zone and director of the Management Committee, led a team, made up by directors of the Management Committee Office of High-tech Zone, personnel bureau, bureau of finance, bureau of science and technology and Gaochuang, to investigate and survey BIOHIT’s production base in Hefei. 

Accompanied by the general manager Feng Liu, Daojun Song and his team visited the laboratory, cleaning shop and so on at the production base, and extended full affirmation to BIOHIT’s gastric mucosa serum detection kit project and its advanced technology. After times of POCT (Point-of-care test) upgrade, BIOHIT products have been proved by repeated laboratory testing to reach the test index of like products provided by internationally-recognized best POCT instrument manufacturers, and have gone far beyond the products provided by its peers at home.

As a Sino-Finland joint venture, BIOHIT Healthcare (Hefei) Co., Ltd. mainly devoted itself to the production and sales of serum gastric function test kits (GastroPanel®) and related supporting devices, and to providing professional technical services. After introducing GastroPanel® which took G-17 as the core, BIOHIT further perfected the concept and application of serum gastric function, and filled in the gaps in serum gastric function detection. Committing itself to upgrading the serum gastric function detection technology, BIOHIT took the lead to automate the test, provided technical guarantee for the application of serum gastric function detection worldwide, and opened up a new era for non-invasive detection of gastric diseases. 

相关链接：http://www.hefei-stip.com.cn/xwdt/yqyw/72311.shtml